{
"info": {
"nct_id": "NCT00003082",
"official_title": "A Phase IA Trial of Combined Murine IgG Monoclonal Anti-Transferrin Receptor Antibodies E2.3 and A27.15 in Cancer Patients",
"inclusion_criteria": "Healthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "",
"miscellaneous_criteria": "DISEASE CHARACTERISTICS: Refractory or recurrent advanced malignancy following known standard effective therapy or advanced malignancy for which no standard effective therapy exists Measurable or evaluable disease\n\nPATIENT CHARACTERISTICS: Age: 18 and over Performance status: SWOG 0-2 Life expectancy: At least 2 months Hematopoietic: Absolute neutrophil count at least 1800/mm3 Hematocrit at least 30 mg/dL Platelet count at least 50,000/mm3 Hepatic: Bilirubin no greater than 1.5 times normal unless due to disease, then less than 3.5 times normal Transaminases less than 3 times upper limit of normal (ULN) (less than 5 times ULN if due to liver metastases) Renal: Creatinine no greater than 2.5 times normal Cardiovascular: No severe cardiac abnormalities Must have adequate venous access No history of sustained ventricular arrhythmia or unexplained syncope Pulmonary: No severe pulmonary abnormalities Other: Not pregnant or nursing Effective contraception required of fertile female patients No serious concurrent medical or psychiatric illness Adequate nutrition No human antimouse antibodies\n\nPRIOR CONCURRENT THERAPY: At least 4 weeks since prior anticancer therapy and recovered If there was disease progression during therapy, at least 2 weeks since prior anticancer therapy and recovered Biologic therapy: Not specified Chemotherapy: No concurrent chemotherapy Endocrine therapy: Concurrent topical steroids used in the chronic management of cutaneous T cell lymphoma allowed No other concurrent hormone therapy Radiotherapy: No concurrent palliative radiotherapy Surgery: Not specified"
},
"inclusion_lines": [
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [],
"miscellaneous_lines": [
{
"line": "DISEASE CHARACTERISTICS: Refractory or recurrent advanced malignancy following known standard effective therapy or advanced malignancy for which no standard effective therapy exists Measurable or evaluable disease",
"criterions": [
{
"exact_snippets": "Refractory or recurrent advanced malignancy",
"criterion": "advanced malignancy",
"requirements": [
{
"requirement_type": "status",
"expected_value": [
"refractory",
"recurrent"
]
}
]
},
{
"exact_snippets": "following known standard effective therapy",
"criterion": "standard effective therapy",
"requirements": [
{
"requirement_type": "status",
"expected_value": "completed"
}
]
},
{
"exact_snippets": "advanced malignancy for which no standard effective therapy exists",
"criterion": "advanced malignancy",
"requirements": [
{
"requirement_type": "standard therapy availability",
"expected_value": false
}
]
},
{
"exact_snippets": "Measurable or evaluable disease",
"criterion": "disease measurability",
"requirements": [
{
"requirement_type": "status",
"expected_value": [
"measurable",
"evaluable"
]
}
]
}
]
},
{
"line": "PATIENT CHARACTERISTICS: Age: 18 and over Performance status: SWOG 0-2 Life expectancy: At least 2 months Hematopoietic: Absolute neutrophil count at least 1800/mm3 Hematocrit at least 30 mg/dL Platelet count at least 50,000/mm3 Hepatic: Bilirubin no greater than 1.5 times normal unless due to disease, then less than 3.5 times normal Transaminases less than 3 times upper limit of normal (ULN) (less than 5 times ULN if due to liver metastases) Renal: Creatinine no greater than 2.5 times normal Cardiovascular: No severe cardiac abnormalities Must have adequate venous access No history of sustained ventricular arrhythmia or unexplained syncope Pulmonary: No severe pulmonary abnormalities Other: Not pregnant or nursing Effective contraception required of fertile female patients No serious concurrent medical or psychiatric illness Adequate nutrition No human antimouse antibodies",
"criterions": [
{
"exact_snippets": "Age: 18 and over",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
},
{
"exact_snippets": "Performance status: SWOG 0-2",
"criterion": "performance status",
"requirements": [
{
"requirement_type": "scale",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "SWOG"
}
}
]
},
{
"exact_snippets": "Life expectancy: At least 2 months",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "months"
}
}
]
},
{
"exact_snippets": "Absolute neutrophil count at least 1800/mm3",
"criterion": "absolute neutrophil count",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 1800,
"unit": "mm3"
}
}
]
},
{
"exact_snippets": "Hematocrit at least 30 mg/dL",
"criterion": "hematocrit",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 30,
"unit": "mg/dL"
}
}
]
},
{
"exact_snippets": "Platelet count at least 50,000/mm3",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 50000,
"unit": "mm3"
}
}
]
},
{
"exact_snippets": "Bilirubin no greater than 1.5 times normal unless due to disease, then less than 3.5 times normal",
"criterion": "bilirubin",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "times normal"
}
},
{
"requirement_type": "conditional maximum",
"expected_value": {
"operator": "<",
"value": 3.5,
"unit": "times normal"
}
}
]
},
{
"exact_snippets": "Transaminases less than 3 times upper limit of normal (ULN) (less than 5 times ULN if due to liver metastases)",
"criterion": "transaminases",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<",
"value": 3,
"unit": "times ULN"
}
},
{
"requirement_type": "conditional maximum",
"expected_value": {
"operator": "<",
"value": 5,
"unit": "times ULN"
}
}
]
},
{
"exact_snippets": "Creatinine no greater than 2.5 times normal",
"criterion": "creatinine",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 2.5,
"unit": "times normal"
}
}
]
},
{
"exact_snippets": "No severe cardiac abnormalities",
"criterion": "cardiac abnormalities",
"requirements": [
{
"requirement_type": "severity",
"expected_value": false
}
]
},
{
"exact_snippets": "Must have adequate venous access",
"criterion": "venous access",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
},
{
"exact_snippets": "No history of sustained ventricular arrhythmia or unexplained syncope",
"criterion": "history of sustained ventricular arrhythmia or unexplained syncope",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No severe pulmonary abnormalities",
"criterion": "pulmonary abnormalities",
"requirements": [
{
"requirement_type": "severity",
"expected_value": false
}
]
},
{
"exact_snippets": "Not pregnant or nursing",
"criterion": "pregnancy or nursing",
"requirements": [
{
"requirement_type": "status",
"expected_value": false
}
]
},
{
"exact_snippets": "Effective contraception required of fertile female patients",
"criterion": "contraception",
"requirements": [
{
"requirement_type": "requirement",
"expected_value": true
}
]
},
{
"exact_snippets": "No serious concurrent medical or psychiatric illness",
"criterion": "serious concurrent medical or psychiatric illness",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Adequate nutrition",
"criterion": "nutrition",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
},
{
"exact_snippets": "No human antimouse antibodies",
"criterion": "human antimouse antibodies",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "PRIOR CONCURRENT THERAPY: At least 4 weeks since prior anticancer therapy and recovered If there was disease progression during therapy, at least 2 weeks since prior anticancer therapy and recovered Biologic therapy: Not specified Chemotherapy: No concurrent chemotherapy Endocrine therapy: Concurrent topical steroids used in the chronic management of cutaneous T cell lymphoma allowed No other concurrent hormone therapy Radiotherapy: No concurrent palliative radiotherapy Surgery: Not specified",
"criterions": [
{
"exact_snippets": "At least 4 weeks since prior anticancer therapy",
"criterion": "time since prior anticancer therapy",
"requirements": [
{
"requirement_type": "time since",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": "recovered",
"criterion": "recovery from prior anticancer therapy",
"requirements": [
{
"requirement_type": "recovery status",
"expected_value": true
}
]
},
{
"exact_snippets": "disease progression during therapy, at least 2 weeks since prior anticancer therapy",
"criterion": "time since prior anticancer therapy after disease progression",
"requirements": [
{
"requirement_type": "time since",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": "recovered",
"criterion": "recovery from prior anticancer therapy after disease progression",
"requirements": [
{
"requirement_type": "recovery status",
"expected_value": true
}
]
},
{
"exact_snippets": "Biologic therapy: Not specified",
"criterion": "biologic therapy",
"requirements": [
{
"requirement_type": "specification",
"expected_value": "Not specified"
}
]
},
{
"exact_snippets": "No concurrent chemotherapy",
"criterion": "concurrent chemotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Concurrent topical steroids used in the chronic management of cutaneous T cell lymphoma allowed",
"criterion": "concurrent topical steroids for cutaneous T cell lymphoma",
"requirements": [
{
"requirement_type": "allowance",
"expected_value": true
}
]
},
{
"exact_snippets": "No other concurrent hormone therapy",
"criterion": "concurrent hormone therapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No concurrent palliative radiotherapy",
"criterion": "concurrent palliative radiotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Surgery: Not specified",
"criterion": "surgery",
"requirements": [
{
"requirement_type": "specification",
"expected_value": "Not specified"
}
]
}
]
}
],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}